Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Diseases | 4 | 2023 | 1253 | 1.050 |
Why?
|
Peer Review | 1 | 2022 | 209 | 0.730 |
Why?
|
Splenic Diseases | 1 | 2020 | 94 | 0.680 |
Why?
|
Cysts | 2 | 2023 | 678 | 0.680 |
Why?
|
Faculty | 1 | 2022 | 386 | 0.680 |
Why?
|
Babesiosis | 1 | 2020 | 92 | 0.660 |
Why?
|
Magnetic Resonance Imaging | 14 | 2023 | 35421 | 0.520 |
Why?
|
Metabolic Diseases | 1 | 2020 | 658 | 0.460 |
Why?
|
Liver | 5 | 2023 | 7474 | 0.440 |
Why?
|
Iron Overload | 2 | 2023 | 242 | 0.390 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2023 | 990 | 0.340 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4253 | 0.330 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 2 | 2022 | 197 | 0.310 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3036 | 0.300 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5256 | 0.290 |
Why?
|
Crohn Disease | 1 | 2018 | 2303 | 0.260 |
Why?
|
Tomography, X-Ray Computed | 10 | 2022 | 20129 | 0.260 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2023 | 198 | 0.190 |
Why?
|
Glomerulonephritis, IGA | 1 | 2020 | 66 | 0.180 |
Why?
|
Splenomegaly | 1 | 2020 | 190 | 0.170 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2019 | 27 | 0.170 |
Why?
|
2-Propanol | 1 | 2019 | 28 | 0.170 |
Why?
|
Digestive System Diseases | 1 | 2020 | 147 | 0.170 |
Why?
|
Hyperammonemia | 1 | 2020 | 76 | 0.170 |
Why?
|
Observer Variation | 2 | 2021 | 2593 | 0.160 |
Why?
|
Elasticity Imaging Techniques | 1 | 2023 | 388 | 0.160 |
Why?
|
Hepatectomy | 1 | 2021 | 550 | 0.160 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 139 | 0.160 |
Why?
|
Hepatitis, Alcoholic | 1 | 2019 | 103 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2019 | 182 | 0.150 |
Why?
|
Prostate | 3 | 2021 | 1774 | 0.150 |
Why?
|
Acidosis | 1 | 2019 | 270 | 0.150 |
Why?
|
Pancreatic Pseudocyst | 1 | 2017 | 110 | 0.150 |
Why?
|
Vascular Fistula | 1 | 2017 | 50 | 0.150 |
Why?
|
Arteriovenous Malformations | 1 | 2020 | 396 | 0.140 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2017 | 131 | 0.140 |
Why?
|
Pancreatic Fistula | 1 | 2017 | 146 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 665 | 0.130 |
Why?
|
Radiology Information Systems | 1 | 2020 | 523 | 0.130 |
Why?
|
Portal Vein | 1 | 2017 | 437 | 0.120 |
Why?
|
Abdomen | 1 | 2020 | 1118 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 711 | 0.110 |
Why?
|
Prostatic Neoplasms | 3 | 2021 | 11124 | 0.110 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.110 |
Why?
|
Humans | 29 | 2023 | 744343 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1170 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1486 | 0.100 |
Why?
|
Male | 20 | 2023 | 350118 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19905 | 0.090 |
Why?
|
Ultrasonography | 2 | 2020 | 5985 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.090 |
Why?
|
Aged | 12 | 2021 | 163280 | 0.080 |
Why?
|
Middle Aged | 14 | 2022 | 213383 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 6234 | 0.080 |
Why?
|
Alcoholism | 1 | 2019 | 1906 | 0.080 |
Why?
|
Erythrocytes | 1 | 2017 | 2455 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57776 | 0.080 |
Why?
|
Standard of Care | 2 | 2022 | 564 | 0.080 |
Why?
|
Kidney | 2 | 2020 | 7186 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3597 | 0.070 |
Why?
|
Female | 15 | 2023 | 380194 | 0.070 |
Why?
|
Child | 3 | 2020 | 77709 | 0.070 |
Why?
|
Wound Healing | 1 | 2018 | 2785 | 0.070 |
Why?
|
Adult | 12 | 2022 | 214055 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2022 | 14722 | 0.070 |
Why?
|
Radiography, Abdominal | 2 | 2019 | 537 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4445 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.060 |
Why?
|
Iron | 2 | 2023 | 1774 | 0.060 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2016 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4262 | 0.050 |
Why?
|
Carcinoembryonic Antigen | 1 | 2023 | 349 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4838 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
Radiopharmaceuticals | 2 | 2022 | 2645 | 0.050 |
Why?
|
Acetone | 1 | 2019 | 43 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6756 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12959 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 239 | 0.040 |
Why?
|
Hematuria | 1 | 2020 | 235 | 0.040 |
Why?
|
Phenobarbital | 1 | 2019 | 193 | 0.040 |
Why?
|
Acid-Base Equilibrium | 1 | 2019 | 185 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 418 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2020 | 372 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 473 | 0.040 |
Why?
|
Poisoning | 1 | 2019 | 249 | 0.040 |
Why?
|
Contrast Media | 2 | 2022 | 5300 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2017 | 163 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 41006 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 592 | 0.040 |
Why?
|
Tachycardia | 1 | 2019 | 619 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13695 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 865 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 354 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 29786 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 72290 | 0.030 |
Why?
|
Hypertension, Portal | 1 | 2017 | 220 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1919 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 2019 | 885 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2020 | 804 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 973 | 0.030 |
Why?
|
Cohort Studies | 3 | 2023 | 40561 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2022 | 1928 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15076 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1863 | 0.030 |
Why?
|
Exanthema | 1 | 2017 | 501 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
Ethanol | 1 | 2019 | 1342 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 1184 | 0.030 |
Why?
|
United States | 1 | 2020 | 69872 | 0.030 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1531 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3479 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1257 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1179 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4851 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1506 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2728 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2017 | 1239 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 5102 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12788 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4251 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11031 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13989 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13881 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8480 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53288 | 0.010 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(81)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_